Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Psychological distress has long been suspected to influence cancer incidence and mortality. It remains largely unknown whether and how stress affects the efficacy of anticancer therapies. We observed that social defeat caused anxiety-like behaviors in mice and dampened therapeutic responses against carcinogen-induced neoplasias and transplantable tumors. Stress elevated plasma corticosterone and upregulated the expression of glucocorticoid-inducible factor Tsc22d3, which blocked type I interferon (IFN) responses in dendritic cell (DC) and IFN-γ + T cell activation. Similarly, close correlations were discovered among plasma cortisol levels, TSC22D3 expression in circulating leukocytes and negative mood in patients with cancer. In murine models, exogenous glucocorticoid injection, or enforced expression of Tsc22d3 in DC was sufficient to abolish therapeutic control of tumors. Administration of a glucocorticoid receptor antagonist or DC-specific Tsc22d3 deletion reversed the negative impact of stress or glucocorticoid supplementation on therapeutic outcomes. Altogether, these results indicate that stress-induced glucocorticoid surge and Tsc22d3 upregulation can subvert therapy-induced anticancer immunosurveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic stress can also selectively suppress the type 1 helper T cells (Th1), suppress the cytotoxic T cells (CTL)-mediated cellular immunity and interferon production, and weaken immune surveillance and other processes, thereby increasing the risk of cancer invasion and metastasis and reducing the effectiveness of anti-tumor therapy (25, 26).”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [25]
In the citing paper
“Yang et al. (25) further confirmed that high levels of corticosteroids in plasma, and the up-regulated glucocorticoid-inducing factor Tsc22d3, blocked the activation of type I IFN response in DCs and IFN-γ+ T cells and reduced the efficacy of anti-tumor therapies in non-small cell lung cancer and colorectal cancer by suppressing the immune surveillance.”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [25]
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Li, T., Fan, J., Wang, B., Traugh, N., Chen, Q., Liu, J. S., Li, B., & Liu, X. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0307 · Cited by 5,913
Tumour heterogeneity and resistance to cancer therapies
Dagogo-Jack, I., & Shaw, A. T. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.166 · Cited by 3,846
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Self-citationPuram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.019 · Cited by 2,182
Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Self-citation
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Immunogenic cell stress and death
Kroemer, G., Galassi, C., Zitvogel, L., & Galluzzi, L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01132-2 · Cited by 1,353
Self-citationImmunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Galluzzi, L., Humeau, J., Buqué, A., Zitvogel, L., & Kroemer, G. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0413-z · Cited by 1,349
Self-citationTurning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.010 · Cited by 534
Cancer neuroscience: State of the field, emerging directions
Winkler, F., Venkatesh, H. S., Amit, M., Batchelor, T., Demir, I. E., Deneen, B., Gutmann, D. H., Hervey-Jumper, S., Kuner, T., Mabbott, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.002 · Cited by 552
Metadata
- Authors
- Yang, H., Xia, L., Chen, J., Zhang, S., Martin, V., Li, Q., Lin, S., Chen, J., Calmette, J., Lu, M., Fu, L., Yang, J., Pan, Z., Yu, K., He, J., Morand, E., Schlecht-Louf, G., Krzysiek, R., Zitvogel, L., Kang, B., Zhang, Z., Leader, A., Zhou, P., Lanfumey, L., Shi, M., Kroemer, G., & Ma, Y.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Nantong University (CN)
- Inserm (FR)
- Université Paris-Sud (FR)
- Shanghai Jiao Tong University (CN)
- Sun Yat-sen University Cancer Center (CN)
- Monash Medical Centre (AU)
- Peking University (CN)
- Icahn School of Medicine at Mount Sinai (US)
- Karolinska University Hospital (SE)
- Corresponding author
- Kroemer, Guido
- Ma, Yuting
- ORCID
- Yang, Heng
- Xia, Lin
- Chen, Jian
- Zhang, Shuqing
- Li, Qingqing
- Lin, Shangqing
- Chen, Jinfeng
- Lu, Min
- Fu, Lingyi
- Yang, Jie
- Pan, Zhizhong
- Yu, Kuai
- He, Jingjing
- Morand, Eric
- Schlecht-Louf, Géraldine
- Krzysiek, Roman
- Zitvogel, Laurence
- Kang, Boxi
- Zhang, Zeming
- Leader, Andrew
- Zhou, Penghui
- Lanfumey, Laurence
- Shi, Minxin
- Kroemer, Guido
- Ma, Yuting
- Venue
- Nature Medicine
- Published
- 2019-09
- Volume
- 25
- Issue
- 9
- Pages
- 1428-1441
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2972373703
- Cited by
- 379
- References
- 64
- Citations by year
- 2026: 66 · 2025: 64 · 2024: 59 · 2023: 60 · 2022: 51 · 2021: 51 · 2020: 24 · 2019: 4
- FWCI
- 25.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Academy of Medical Sciences (NAF\R1\180216)
- Agence Nationale de la Recherche (ANR-10-LABX-0015, ANR-18-IDEX-0001)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- psychological stress, glucocorticoids, TSC22D3, social defeat, anxiety-like behavior, corticosterone, type I interferon, dendritic cells, T cell activation, immunosuppression, cancer immunotherapy, chemoresistance, glucocorticoid receptor antagonist, tumor-infiltrating immune cells
- MeSH terms
- Animals, Anxiety, Behavior, Animal, Carcinogens, Corticosterone, Dendritic Cells, Glucocorticoids, Humans, Hydrocortisone, Immunity, Cellular, Lung Neoplasms, Lymphocyte Activation, Neoplasms, Receptors, Glucocorticoid, Stomach Neoplasms, Stress, Psychological, Transcription Factors, Monitoring, Immunologic, Colorectal Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. https://app.cochat.ai/papers/10.1038/s41591-019-0566-4
- The paper
- Yang, H., Xia, L., Chen, J., Zhang, S., Martin, V., Li, Q., Lin, S., Chen, J., Calmette, J., Lu, M., Fu, L., Yang, J., Pan, Z., Yu, K., He, J., Morand, E., Schlecht-Louf, G., Krzysiek, R., Zitvogel, L., . . . Ma, Y. (2019). Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nature Medicine. https://doi.org/10.1038/s41591-019-0566-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.